148 related articles for article (PubMed ID: 35865938)
21. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
[TBL] [Abstract][Full Text] [Related]
22. Lung hyperinflation quantitated by chest CT in children with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell transplantation.
Moutafidis D; Gavra M; Golfinopoulos S; Oikonomopoulou C; Kitra V; Woods JC; Kaditis AG
Clin Imaging; 2021 Jul; 75():97-104. PubMed ID: 33515927
[TBL] [Abstract][Full Text] [Related]
23. Ruxolitinib is an effective salvage treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation without posttransplant cyclophosphamide.
Zhao JY; Liu SN; Xu LP; Zhang XH; Wang Y; Chen YH; Liu KY; Huang XJ; Mo XD
Ann Hematol; 2021 Jan; 100(1):169-180. PubMed ID: 33159239
[TBL] [Abstract][Full Text] [Related]
24. Ruxolitinib treatment for SR-aGVHD in patients with EBV-HLH undergoing allo-HSCT.
Meng G; Wang J; Wang X; Wang Y; Wang Z
Ann Hematol; 2020 Feb; 99(2):343-349. PubMed ID: 31879790
[TBL] [Abstract][Full Text] [Related]
25. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
Ahn JH; Jo KW; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
Clin Transplant; 2015 Dec; 29(12):1133-9. PubMed ID: 26383085
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
[TBL] [Abstract][Full Text] [Related]
27. Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease.
Brownback KR; Thomas LA; McGuirk JP; Ganguly S; Streiler C; Abhyankar S
Lung; 2017 Dec; 195(6):781-788. PubMed ID: 28894914
[TBL] [Abstract][Full Text] [Related]
28. [A retrospective study of 10 cases of post-transplant bronchiolitis obliterans].
Chai JJ; Liu T; Cai BQ; Zhu HD
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jul; 40(7):504-508. PubMed ID: 28728274
[No Abstract] [Full Text] [Related]
29. Ruxolitinib salvage therapy is effective for steroid-refractory graft-versus-host disease in children: A single-center experience.
Uygun V; Karasu G; Daloğlu H; Öztürkmen S; Kılıç SÇ; Yalçın K; Çelen SS; Hazar V; Yeşilipek A
Pediatr Blood Cancer; 2020 Apr; 67(4):e28190. PubMed ID: 31981413
[TBL] [Abstract][Full Text] [Related]
30. Association between chronic bacterial airway infection and prognosis of bronchiolitis obliterans syndrome after hematopoietic cell transplantation.
Yomota M; Yanagawa N; Sakai F; Yamada Y; Sekiya N; Ohashi K; Okamura T
Medicine (Baltimore); 2019 Jan; 98(1):e13951. PubMed ID: 30608429
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of high-dose steroids for bronchiolitis obliterans syndrome post pediatric hematopoietic stem cell transplantation.
Even-Or E; Ghandourah H; Ali M; Krueger J; Sweezey NB; Schechter T
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29417689
[TBL] [Abstract][Full Text] [Related]
32. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
[TBL] [Abstract][Full Text] [Related]
33. Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience.
Xue E; Lorentino F; Pavesi F; Assanelli A; Peccatori J; Bernardi M; Corti C; Ciceri F; Lupo Stanghellini MT
Leuk Res; 2021 Oct; 109():106642. PubMed ID: 34157510
[TBL] [Abstract][Full Text] [Related]
34. Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Walther S; Rettinger E; Maurer HM; Pommerening H; Jarisch A; Sörensen J; Schubert R; Berres M; Bader P; Zielen S; Jerkic SP
Pediatr Pulmonol; 2020 Jul; 55(7):1725-1735. PubMed ID: 32369682
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis.
Denk A; Mittermaier C; Weber D; Fante M; Güneş S; Edinger M; Herr W; Wolff D
Ann Hematol; 2024 Jun; ():. PubMed ID: 38916742
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and safety of ruxolitinib in the salvage treatment of chronic graft versus-host disease].
Ji YP; Tang BL; Zhu XY; Liu HL; Song KD; Wan X; Yao W; Sun GY; Wang J; Sun ZM
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(16):1235-1239. PubMed ID: 32344495
[No Abstract] [Full Text] [Related]
37. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
[TBL] [Abstract][Full Text] [Related]
38. [Clinical analysis of lung transplantation in eight patients with obstructive bronchiolitis syndrome after hematopoietic stem cell transplantation].
Wang LL; Wang HY; Shen YF; Lu MZ; Chen JY; Wu B
Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):977-980. PubMed ID: 29224324
[No Abstract] [Full Text] [Related]
39. Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults.
Wang YM; Teusink-Cross A; Elborai Y; Krupski MC; Nelson AS; Grimley MS; Flannery A; Mehta PA; Bleesing JJ; Chandra S; Kumar AR; Myers KC; Davies SM; Khandelwal P
Transplantation; 2022 Feb; 106(2):412-419. PubMed ID: 33795598
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
